Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

SOLU-MEDROL

METHYLPREDNISOLONE SODIUM SUCCINATE

Standard Dose
EQ 40MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SOLU-MEDROL is listed in Drugs@FDA under application 011856 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient METHYLPREDNISOLONE SODIUM SUCCINATE Form and strength INJECTABLE;INJECTION - EQ 40MG BASE/VIAL Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 2025-11-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview SOLU-MEDROL is listed in Drugs@FDA under application 011856 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient METHYLPREDNISOLONE SODIUM SUCCINATE Form and strength INJECTABLE;INJECTION - EQ 40MG BASE/VIAL Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 2025-11-04 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
SOLU-MEDROL (METHYLPREDNISOLONE SODIUM SUCCINATE) | Drug Monograph | MedicHelpline